Scholarly Index

Pierfranco Conté

University of Padua; 43,432 total citations; 1,094 total publications; best world rank #43

University of Padua

43,432Total citations

1,094Total publications

93H-index

Published ranking records

Field	Window	World rank	National rank	Impact score
Cancer Treatment and Pharmacology	Lifetime	70	IT 5	99.74
Advanced Breast Cancer Therapies	Lifetime	43	IT 4	99.56
HER2/EGFR in Cancer Research	Lifetime	96	IT 7	99.55
Breast Cancer Treatment Studies	Lifetime	132	IT 10	99.54
Chemotherapy-induced cardiotoxicity and mitigation	Lifetime	59	IT 5	98.42
Cancer Diagnosis and Treatment	Lifetime	291	IT 20	98.33
Ovarian cancer diagnosis and treatment	Lifetime	298	IT 25	98.64
Colorectal Cancer Treatments and Studies	Lifetime	487	IT 41	98.53
Intraperitoneal and Appendiceal Malignancies	Lifetime	151	IT 20	97.88
Cancer Immunotherapy and Biomarkers	Lifetime	885	IT 52	98.17
Chemotherapy-related skin toxicity	Lifetime	96	IT 7	96.09
Lung Cancer Research Studies	Lifetime	721	IT 47	97.62
PARP inhibition in cancer therapy	Lifetime	368	IT 15	95.65
Economic and Financial Impacts of Cancer	Lifetime	412	IT 10	95.70
Neutropenia and Cancer Infections	Lifetime	536	IT 33	95.67
PI3K/AKT/mTOR signaling in cancer	Lifetime	907	IT 40	93.80
Chemotherapy-induced organ toxicity mitigation	Lifetime	225	IT 5	91.93
Breast Cancer Treatment Studies	2021-2025	69	IT 8	99.02
HER2/EGFR in Cancer Research	2021-2025	94	IT 8	98.49
Advanced Breast Cancer Therapies	2021-2025	114	IT 10	98.14
Lung Cancer Treatments and Mutations	2021-2025	613	IT 42	96.18
Cancer Treatment and Pharmacology	2021-2025	390	IT 25	92.08
PI3K/AKT/mTOR signaling in cancer	2021-2025	569	IT 26	68.45